The growth inhibitory effect of p21 adenovirus on androgen‐dependent and ‐independent human prostate cancer cells

Akinobu Gotoh, Toshiro Shirakawa, Yoshitaka Wada, M. Fujisawa, Hiroshi Okada, Sadao Kamidono, Katsuyuki Hamada

British Journal of Urology · 2003 · 15 citations · 20 references

Abstract

These results suggest that Ad5CMV-p21 may be a new therapeutic agent for human prostate cancer gene therapy.

References

20